A Phase 3 interventional study of Vitamin A and Vitamin A and ZInc in Malaria, sponsored by University of Ghana. Completed at 1 site in Ghana. Open to female participants. Per ClinicalTrials.gov, last updated 2016-08-25.
Sponsored by University of Ghana · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Malaria with a site in Ghana — 5 open to participants now, 6 under way, none of them phase 3. Malaria · Ghana.
Among the 59 studies in Malaria with a site in Ghana, this one is the 31st largest by enrollment of the 47 interventional ones that give a count, is one of 6 that started in 2011, is one of 13 in phase 3, and was the 44th registered.
1,187 studies on the registry are indexed under Malaria; 80 are open to participants now.
Browse Malaria studies →5 of the 59 studies in Malaria with a site in Ghana are open now. Recruiting first, the newest first:
University of Michigan · Sites in Ghana
Ages 15–49 · Women only · Healthy volunteers
Novartis Pharmaceuticals · Sites in Ghana, Burkina Faso, Côte D'Ivoire and 3 more countries
Ages 2–100
Noguchi Memorial Institute for Medical Research · Sites in Ghana
Ages 3 mo+ · Healthy volunteers
Kintampo Health Research Centre, Ghana · Sites in Ghana, Kenya, Malawi
Ages 6 mo–59 mo
Bernhard Nocht Institute for Tropical Medicine · Sites in Ghana
Ages 18+ · Women only · Healthy volunteers
A study can be open while its sites in Ghana have not opened yet or have stopped. Only those recruiting at a site in Ghana →
Of the 51 Malaria studies recruiting now, 15 (29%) set no upper age limit and 33 (65%) stop at 75 or younger; 37 take children under 18; 31 take healthy volunteers.
This study: female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 7 · Phase 3 15 · Phase 4 12
First in 2000; this study’s year is marked. 6 started in 2011.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 547 is above the median of 252 across 939 interventional studies indexed under Malaria.
Median enrollment 1,490 across the 47 interventional studies, 1,800 across the 11 observational. Of the 48 that completed or were terminated, 16 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 59 have an industry lead sponsor. The 10 most frequent:
University of Ghana is the lead sponsor of 8 studies on the registry; 2 are open to participants now.
University of Ghana has 2 studies filed under Malaria — fewer than ten, so there is no comparison to draw.
1 of the studies in Malaria with a site in Ghana that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07389057Noguchi Memorial Institute for Medical ResearchAssessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana | 2026-11-30 |
Add it to your calendar (.ics) → With an account.
Among the 59 studies in Malaria with a site in Ghana, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study was to determine the effect of combining vitamin A (VA), zinc (Z) and multivitamins (MV- A, B1, B2, B6, B12, C, D and E) on malaria morbidity
A total of 542 children aged between 6-59 months received either: (i) VA (control) or (ii) VA \& Z (VAZ) or (iii) VA, Z \& MV (VAZM). VA was delivered as a single dose while MV and Z were delivered daily. Malaria cases were managed by community health workers, who used rapid diagnostic test to confirm infection prior to treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A single dose of 20,000IU Vitamin A for the whole study period
Dietary Supplement: Vitamin A
A single dose of 20,000IU Vitamin A and 10mg of elemental zinc each day for 5 months
Dietary Supplement: Vitamin A and ZInc
A single dose of 20,000IU Vitamin A , 10mg of elemental zinc each day and 0.5ml/kg multivitamin syrup for 5 months
Dietary Supplement: Vitamin A , Zinc and Multivitamin
Vitamin A supplements
Also known as: VA
Drug pages: Vitamin AStudies of Vitamin AVitamin A pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · ZincStudies of ZincZinc pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
Combination of vitamin A and zinc supplements
Also known as: VAZ
Drug pages: Vitamin AStudies of Vitamin AVitamin A pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · ZincStudies of ZincZinc pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · GeritolStudies of GeritolGeritol pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
Combination of vitamin A, zinc and multivitamins
Also known as: VAZM
Incidence of clinical malaria attacks
While taking the supplement, malaria incidence will be measured
Time frame: Baseline and every month up to six months
Incidence of diarrhea attacks
While taking the supplement, diarrhea incidence will be measured
Time frame: Every month up to six months
Plan to share: Yes — To meet the participants and explain the results of their data to them
The record gives a start of Nov 2011, a primary completion of May 2012 and a completion of Dec 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Vitamin A · Zinc · Geritol
University of Ghana